US Stock MarketDetailed Quotes
IRON Disc Medicine
- 64.500
- -0.460-0.71%
Close Nov 25 16:00 ET
- 64.500
- 0.0000.00%
Post 20:02 ET
1.92BMarket Cap-16329P/E (TTM)
68.190High64.350Low410.85KVolume65.970Open64.960Pre Close26.77MTurnover2.48%Turnover RatioLossP/E (Static)29.76MShares77.60052wk High4.10P/B1.07BFloat Cap25.60052wk Low--Dividend TTM16.60MShs Float190.850Historical High--Div YieldTTM5.91%Amplitude11.600Historical Low65.165Avg Price1Lot Size
Disc Medicine Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -132.22%-17.36M | -20.98%-15.39M | 5.26%-33.6M | -73.87%-73.46M | -84.13%-17.8M | 22.86%-7.48M | -38.39%-12.72M | -158.86%-35.47M | -53.45%-42.25M | -149.57%-9.67M |
| Net income from continuing operations | -88.35%-26.6M | -65.25%-26.35M | -18.30%-26.95M | -63.22%-76.43M | -109.70%-23.58M | 12.56%-14.12M | -66.46%-15.95M | -131.21%-22.78M | -30.19%-46.83M | -162.20%-11.24M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -98.79%61K | ---3.39M |
| Depreciation and amortization | -56.00%11K | 340.00%110K | 4.00%26K | 12.36%100K | 0.00%25K | 4.17%25K | 13.64%25K | 38.89%25K | 178.13%89K | 116.34%25K |
| Other non cash items | 17.93%-659K | -90.19%152K | 69.05%142K | 37.44%290K | -759.76%-541K | -1,079.27%-803K | 5,840.74%1.55M | 13.51%84K | -86.47%211K | 108.13%82K |
| Change In working capital | 30.81%8.05M | 2,024.48%7.2M | 21.29%-10.88M | -238.96%-2.95M | 13.03%4.37M | 20,413.33%6.15M | -85.87%339K | -231.21%-13.82M | 65.24%2.13M | 23.22%3.87M |
| -Change in prepaid assets | 419.72%1.11M | 140.93%2.5M | -352.86%-4.11M | -431.25%-1.17M | -173.84%-1.51M | 24.56%213K | -22.40%1.04M | 71.58%-908K | 125.77%352K | -25.29%2.04M |
| -Change in payables and accrued expense | 19.95%7.06M | 873.30%4.9M | 47.88%-6.69M | -185.45%-1.73M | 207.63%5.85M | 12,986.67%5.89M | -160.46%-633K | -1,231.33%-12.83M | -29.02%2.03M | 10.40%1.9M |
| -Change in other current assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | 200.00%64K | --0 |
| -Change in other current liabilities | -332.69%-121K | -195.31%-189K | 1.32%-75K | 83.07%-54K | 146.58%34K | 127.96%52K | -476.47%-64K | 1.30%-76K | -126.24%-319K | ---73K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -132.22%-17.36M | -20.98%-15.39M | 5.26%-33.6M | -73.87%-73.46M | -84.13%-17.8M | 22.86%-7.48M | -38.39%-12.72M | -158.86%-35.47M | -53.45%-42.25M | -149.57%-9.67M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -157,877.78%-71.09M | -1,831,141.67%-219.75M | -131.03%-67K | 41.06%-89K | 75.00%-3K | -136.84%-45K | 40.00%-12K | 71.00%-29K | -122.06%-151K | -71.43%-12K |
| Net PPE purchase and sale | 117.78%8K | 125.00%3K | -131.03%-67K | 41.06%-89K | 75.00%-3K | -136.84%-45K | 40.00%-12K | 71.00%-29K | -122.06%-151K | -71.43%-12K |
| Net investment purchase and sale | ---71.1M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -157,877.78%-71.09M | -1,831,141.67%-219.75M | -131.03%-67K | 41.06%-89K | 75.00%-3K | -136.84%-45K | 40.00%-12K | 71.00%-29K | -122.06%-151K | -71.43%-12K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -7.39%426K | 12.57%173.19M | -79.43%15.9M | 60.68%239.38M | -94.79%7.76M | 1,990.91%460K | 178,801.16%153.86M | 140,456.36%77.31M | 65.66%148.98M | 244.86%148.82M |
| Net common stock issuance | -71.00%-171K | 20.38%172.62M | -69.59%14.85M | 272.11%199.08M | -87.01%6.95M | ---100K | --143.4M | --48.82M | --53.5M | --53.5M |
| Proceeds from stock option exercised by employees | 6.61%597K | -94.57%567K | -96.31%1.05M | 18,302.28%40.3M | 1,339.29%806K | 2,445.45%560K | 12,052.33%10.45M | 51,689.09%28.48M | 222.06%219K | 233.33%56K |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --95.26M | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -7.39%426K | 12.57%173.19M | -79.43%15.9M | 60.68%239.38M | -94.79%7.76M | 1,990.91%460K | 178,801.16%153.86M | 140,456.36%77.31M | 65.66%148.98M | 244.86%148.82M |
| Net cash flow | ||||||||||
| Beginning cash position | -25.63%280.9M | 44.91%342.85M | 85.13%360.62M | 120.82%194.79M | 566.05%370.66M | 478.09%377.72M | 217.72%236.6M | 120.82%194.79M | 240.77%88.21M | -63.00%55.65M |
| Current changes in cash | -1,146.64%-88.03M | -143.90%-61.95M | -142.49%-17.77M | 55.60%165.83M | -107.22%-10.04M | 27.12%-7.06M | 1,646.00%141.12M | 404.17%41.81M | 70.99%106.58M | 267.15%139.14M |
| End cash Position | -47.96%192.87M | -25.63%280.9M | 44.91%342.85M | 85.13%360.62M | 85.13%360.62M | 566.05%370.66M | 478.09%377.72M | 217.72%236.6M | 120.82%194.79M | 120.82%194.79M |
| Free cash flow | -130.73%-17.35M | -20.84%-15.39M | 5.15%-33.67M | -73.46%-73.55M | -83.93%-17.8M | 22.55%-7.52M | -38.22%-12.74M | -157.19%-35.5M | -53.62%-42.4M | -149.65%-9.68M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data